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Abstract Protein kinases share a considerable sequence homol- 
ogy in their catalytic core (residues 40-300 in PKA). Each core is 
flanked by "head" and "tail" segments at its amino- and 
carhoxy-termini, which are different in the various kinases. 
These end segments may play an important role in creating the 
preferential affinity of each kinase for its physiological 
substrates or regulatory ligands. Here we describe three anti- 
peptide antibodies (~P-1, o.P-2, and c¢P-3) that specifically 
recognize the head and tail segments of the catalytic subunit (C) 
of PKA. (i) otP-I (against 6A-Kt3) react with C when denatured 
but not when in its native structure; (ii) ffP-2 (against 319K-I33S), 
bind to the site in C cleaved by the kinase splitting membranai 
proteinase (KSMP) and inhibit this cleavage of C; (iii) otP-3 
(against 33SS-F3S°) react with C but not with the KSMP cleavage 
product C', useful for detecting a KSMP-like activity in different 
tissues and subcellular loci. The combined use of the antibodies 
described here provides a strict definition of C, and thus a high 
degree of fidelity in its biorecognition. 
Key words: Anti-peptide antibodies; Inhibitory antibodies; 
KSMP;  Protein kinase A; Tails of protein kinases 
1. Introduction 
The catalytic subunit (C) of protein kinase A (PKA) [1,2] is 
regarded as a prototype for the large family of protein kinases 
[3,4], each having its own substrate specificity and a distinct 
mechanism of regulation. These kinases share a considerable 
sequence homology in a conserved catalytic ore (residues 40- 
300 in PKA), which is flanked by a "head" and a "tai l" 
segment found (respectively) at its amino- and at its car- 
boxy-terminus (Fig. 1) [5-8]. Since the kinases differ signifi- 
cantly in the sequence of their head and tail segments, it seems 
reasonable to assume that these segments play an important 
structural and functional role, e.g., in forming the preferential 
affinity of  each kinase for its physiological substrates or reg- 
ulatory ligands. 
We have previously identified a kinase splitting membranal 
proteinase (KSMP), which specifically cleaves C to yield a 
distinct clipped product C' devoid of kinase activity [9-11]. 
The cleavage was shown to occur in the native structure of C, 
but not if C is pre-denatured [10,11], suggesting that KSMP 
recognizes the conformation of the kinase. More recently we 
have shown that the cluster of acidic amino acids at the car- 
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Abbreviations: C, catalytic subunit of cAMP-dependent protein 
kinase; DAB, 3,3'-diaminobenzidine; KLH, keyhole limpet hemocya- 
nin; KSMP, kinase-splitting membranal proteinase; C', KSMP-cleaved 
C; PKA, protein kinase A (cAMP-dependent protein kinase). 
boxy-terminus tail of C (327FDDYEEEEI335) is the major 
biorecognition element for KSMP, since antiidiotypic mono- 
clonal antibodies against a copolymer containing clusters of E 
and Y were found to inhibit KSMP [12]. A similar conforma- 
tion-dependent cleavage by KSMP was shown to occur also in 
two other protein kinases which contain such clusters of acidic 
amino acids at their carboxy-terminus tail - -  the EGF  recep- 
tor kinase, and the insulin receptor kinase [13,14], raising the 
possibility that the malleable tails at the carboxy terminus of 
these kinases may play an important role in their biorecogni- 
tion and regulation [13-16]. This paper describes the prepara- 
tion and characterization of anti-head and anti-tail antibodies 
against distinct epitopes in C, and their use in the specific 
identification of PKA and in the assay of KSMP by the de- 
termination of C and C'. 
2. Materials and methods 
2.1. Preparation and assay of C 
The C subunit of bovine PKA was purified as described by Rei- 
mann and Beham [17]. This purification involves chromatography on
DE-52, affinity elution of C by cAMP, and chromatography on hy- 
droxylapatite. To this procedure we added a purification step on a 
Mono S column (HR 5/5, Pharrnacia, Sweden). The fractions with 
kinase activity obtained from the hydroxylapatite column were 
pooled, dialyzed against an equilibration buffer composed of 20 mM 
NaPi (pH 6.8), 1 mM EDTA and 1 mM DTT, and then applied on 
the Mono S column, which was pre-equilibrated with the same buffer. 
The loaded column was washed with the equilibration buffer, then 
eluted with a linear gradient of NaPi (20 mM to 200 mM, pH 6.8). 
This column yields two iso-forms of the C subunit: CA and CB 
[18,19]. The CB isoform was used in this study, since it was previously 
shown that it constitutes a slightly better substrate for KSMP [20]. 
The enzyme was assayed as described previously [21] with the follow- 
ing modification: the phosphoprotein pellet formed by precipitation 
with trichloroacetic a id was washed on GF/C glass filters (Whatman, 
UK). 
2.2. Preparation of the kinase splitting membranal proteinase (KSMP) 
Brush-border membranes from rat kidney were purified by the pro- 
cedure of Evers et al. [22], which is based on a precipitation of the 
membranes by Ca2+-ions. This procedure yields a membrane prepara- 
tion enriched with KSMP. This membrane preparation was solubi- 
lized with 1% octyl-l]-o-glucopyranoside [10,11,23], the insoluble par- 
ticles were removed by centrifugation at 100 000 ×g for 30 rain, and 
the resulting supernatant (protein concentration, 1 mg/ml) was used in 
the present study. 
2.3. Assay of KSMP 
KSMP was assayed as described previously [9,10] with the following 
modifications: the reaction mixtures used had a total volume of 20 BI 
and contained 1/.tg of C, 100 ng of KSMP preparation i a buffer (pH 
7.1) composed of Tris-HCl (20 raM), MgCI2 (1.5 mM) and 13-octyl- 
glucoside (0.2% w/v). The reaction was allowed to proceed at 23°C for 
the time indicated, and arrested by adding the sample buffer used for 
polyacrylamide gel electrophoresis in the presence of SDS, described 
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by Laemmli [24], then boiling (5 min at 95°C). The gels used had 
usually a polyacrylamide gradient of 5 to 20%, and were stained 
with Coomassie blue (0.25%, w/v) in 50% (v/v) methanol and 7"/,, (v/ 
v) acetic acid. 
2.4. Raising and purifying anti-peptide antibodies 
The synthesized peptides were designated as follows: P-l, <~AK- 
KGSEQESVKEFLAKAK 23 ; P-2, 3agKGPGDTSNFDDYEEEEI3:~;'; 
P-2', 327FDDYEEEEIaas, and P-3, 33SSINEKCGKEFSEF:~5°, where 
the numbers correspond to the positions of the amino acid residues in 
the C sequence. These peptides were synthesized on a solid-phase 
synthesizer, purified by reverse phase HPLC and analysed by amino 
acid composition or sequence before use. Three of these peptides (P-l, 
P-2 and P-3) were then cross-linked with KLH (Pierce, USA) as a 
carrier, and the resulting conjugates were used for immunization. The 
cross-linking and the protocol of injections were carried out as de- 
scribed by Harlow [25]. All the anti-peptide antibodies used in the 
present study were affinity purified as described below [25]. The im- 
mune sera obtained were fractionated by an ammonium sulfate pre- 
cipitation (repeated twice), and the resulting IgG fractions were 
passed through a column with immobilized KLH to remove the 
anti-KLH specific antibodies. The resulting anti-KLH depleted IgG 
fractions were then affinity purified on the corresponding peptides 
immobilized on agarose beads. The elution from the KLH- and the 
peptide-columns was performed by GIy-HC1, pH 2.4, and by triethyl- 
amine, pH 11.5. The eluate from the KLH column was used as ne- 
gative control. 
2.5. Western blot analysis of C and C' 
The transfer of proteins onto nitrocellulose paper and immuno- 
staining were carried out as described in the literature [25]. Visualiza- 
tion of the C and C' protein bands after SDS-PAGE was performed 
using horseradish peroxidase conjugated secondary antibodies (Sigma, 
USA), and either by the ECL detection system (Amersham, USA) or 
by the use of DAB (Sigma, USA) as a substrate. When the immuno- 
staining was performed in the presence of different peptides, the pep- 
tides were preincubated with the first antibodies for 15 30 rain at 
room temperature before applying on the nitrocellulose blots. 
2.6. Preparation of C mutants 
The wild type murine Ca-subunit gene was inserted into the 
pRSET-B vector (Invitrogen, USA) as described elsewhere (Yonemo- 
to et al., submitted). It was a gift from Dr. Susan Taylor (University 
of California, San Diego). Site directed mutations were introduced by 
oligonucleotide-directed mutagenesis of a uracil-containing single- 
stranded Kunkel template [26]. The vectors harboring the mutated 
enzyme genes were used for the transformation of the E. coli BL21 
(DE-3) strain. The conditions used for growing and for induction of 
the bacteria were described elsewhere [27,28]. After induction, the cells 
were collected, lysed in the SDS-PAGE loading buffer [24], and used 
for Western blot analysis. 
2. 7. Cell-free translation of C and mutants 
The coupled transcription and translation in the rabbit reticulocyte 
lysate system (TNT system, Promega, USA) was used for cell-free 
expression of the wild type or mutated C-subunit. pRSET expression 
vector (Invitrogen, USA), carrying the genes of the wild type or the 
mutated kinase, was used as a template. All the manipulations were 
done according to the Promega TNT system protocol. The translation 
products were labeled by [35S]methionine (Amersham, UK) in the 
course of the reaction, then separated by SDS-PAGE and visualized 
by autoradiography. 
2.8. Immunoprecipitation f in vitro translated C 
The immunoprecipitation was performed as described by Harlow 
[25] with the following modifications: Affinity purified antipeptide or 
control antibodies (1 gg per assay) were preincubated with 5 p.1 of 
Protein A sepharose (Pharmacia, Sweden) in a final volume of 20 gl 
for 30 min at 4°C. The resin was washed three times with PBS with 
0.05% Tween 20, and resuspended in 20 I.tl of the same buffer. To this 
resin 1 gl of TNT-translation mixture, containing [35S]methionine-la- 
belled C, was added and incubated for 1 h at room temperature with 
agitation. The resin was washed again three times with PBS with 
0.05% Tween 20, two times with 20 mM Tris-HCl pH 7.1, and then 
resuspended in the SDS-PAGE loading buffer mentioned above [24]. 
3. Results and discussion 
3.1. Choice of  epitopes 
The purpose of this study was (a) to obtain antibodies that 
would specifically recognize the C subunit of PKA, rather 
than other members of the protein kinase family, and refrain 
from cross-reacting with other protein kinases which share a 
considerable sequence homology with the catalytic core of C 
(residues 40-300) [3,4]), and (b) to obtain a set of antibodies 
with which it would be possible to detect both C and C' and 
thus to detect and localize a KSMP-like activity in different 
cells and tissues, so as to assess the possible involvement of 
such an enzyme in the regulation of PKA. For this purpose 
we synthesized three peptides whose sequences were identical 
to three epitopes in C; one in the head of the enzyme and two 
in its tail (Fig. 1A). 
The peptides had the following structures: P-l ,  
6AKKGSEQESVKEFLAKAK23;  P-2, 319KGPGDTSNFD- 
DYEEEEI335; and P-3, 33SSINEKCGKEFSEF35°. Each of 
them was purified by reverse phase HPLC, analysed, then 
cross-linked with KLH and used for immunization. The 
anti-peptide antibodies were then affinity purified as described 
below on a column containing the respective immobilized pep- 
tide. As seen in the example depicted in Fig. 1B, all three 
antibodies (aP-1, c~P-2, and ~P-3) reacted specifically with C 
on SDS-PAGE gels of total cell lysates. 
3.2. Specificity of  the otP-1, o~P-2, and aP-3 antibodies 
One of our major objects in the preparation of these anti- 
bodies was to be able to identify both C and its KSMP cleav- 
age product C'. Since the substrate recognition region of 
KSMP was previously shown to reside mainly in the cluster 
of acidic amino acids (327FDDYEEEE1335) found at the car- 
boxy-terminus tail of C [12], we expected that while c~P-1 
would recognize and stain both C and C', c~P-3 antibodies 
(which were raised against an epitope downstream from the 
cluster of acidic amino acids) would do so with C but not with 
C'. Indeed, this was found to be the case: when C was par- 
tially cleaved by KSMP to create a mixture of C and C' and 
the components in the reaction mixture were stained with 
Coomassie blue (to stain both C and C') or with c~P-1 and 
c~P-3 (to stain the head and the tail of C) it was found that 
c~P-1 stains both C and C' while aP-3 stains C but not C' 
(Fig. 2A). Unexpectedly, the c@-2 antibodies, which were de- 
signed to recognize in C the binding site of KSMP [12], as well 
as the specific KSMP cleavage site (332E-E333) [29] stained also 
C' (see Fig. 1A and 2A). To get an insight into this apparent 
discrepancy, we studied the effect of some of the peptides on 
the staining of C by aP-2. As seen in Fig. 2B, the peptide P-2, 
at concentrations >10 -7 M completely inhibited the binding 
of c~P-2 to C, while the peptide P-2' (327FDDYEEEEI335) 
failed to do so up to a concentration of 10 -4 M. In that 
respect it was similar to the head peptide P-I (see Fig. 1A 
and 2B) which also afforded C with no protection from stain- 
ing by aP-2. This result suggests that the immuno-dominant 
moiety in the peptide resides in the stretch 319KGPGDTSN326 
rather than the stretch 327FDDYEEEEI335. 
3.3. Deletion mutants of C confirm the specificity of o~P-2 
For further analysis of the specificity of the ~P-2 antibodies 
we constructed three deletion mutants of  C lacking different 
fragments of the designed epitope of the e~P-2 antibodies. 
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Fig. 1. Design of synthetic peptides and the specificity of the raised anti-peptide antibodies, (A) Sequence of the peptides used for the raising 
of epitope-specific antibodies against he C subunit of PKA. The gray part represents the conserved core of protein kinases (residues 40-300). 
The sequence and location in C of the head and tail peptide segments used for the preparation of the anti-peptide antibodies are indicated and 
designated P-l, P-2, P-3. A fragment peptide of P-2 with the indicated sequence (used in inhibition studies) is designated P-2'. (B) Specificity of 
the anti-peptide antibodies. A Western blot analysis was carried out with samples of purified bovine C (20 ng protein per lane) without (lanes 
marked 1), or with (lanes marked 2) 20/,tg of a protein mixture obtained from a crude lysate of 293 cells. The panel marked CB was stained 
with Coomassie blue, and the other panels were stained each with the indicated antibody. In the CB panel lane 1" contained 0.5 ~g (rather 
than 20 ng) of purified bovine C to allow visualization with CB. 
These mutants of C had deletions of the following segments: 
319K-F327 (A9), 319K-D323 (A5), and 324T-F327 (A4) (Fig. 3A) 
These mutant C subunits were expressed in E. coil as de- 
scribed in section 2 [27,30], then subjected to a Western blot 
analysis staining with either ~P-2 or ~P-3. As seen in Fig. 3B, 
all of these deletion mutants interacted with e~P-3, but none of 
them interacted with c~P-2. Since these deletions in C were 
found to prevent the recognition of  both C and C' by ~P-2, 
and since these findings are in agreement with the results 
described above regarding the inhibition of the interaction 
between ctP-2 and C by peptides, it seems reasonable to con- 
clude that the segment 319K-F327 in C is indeed the immuno- 
dominant determinant of the ctP-2 antibodies. 
3.4. ctP-2 antibodies inhibit the KSMP cleavage of C 
In view of the specificity established above for the c~P-2 
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Fig. 2. Specificity of the anti-peptide antibodies. (A) Western blot of C and C' after SDS-PAGE, developed with the indicated antibodies. A
preparation of pure bovine C was subjected to proteolysis by KSMP under conditions yielding a ~ 50% degradation of the kinase. Aliquots 
from the resulting reaction mixture (50 ng protein for immunodetection, and 0.5 ~tg protein for staining with Coomassie blue (CB)) were sub- 
jected to SDS-PAGE, blotted onto nitrocellulose, and stained with the indicated antibodies (c~P-1, ~P-2, and c~P-3). (B) Quantitative assessment 
of the c~P-2 inhibition of the staining by the synthetic peptides indicated. A Western blot of the C preparation (bovine, 50 ng per lane) was 
stained by aP-2 antibodies that were preincubated (22°C, 30 rain) with the indicated concentrations of P-l, P-2, and P-2'. The blot was devel- 
oped by an ECL detection system, and the relative cross-reactivity with C was assessed by the integrated volume of the stained bands deter- 
mined by computer densitometry scanning of the film. 
antibodies, it was of interest o find out whether they could be 
used as inhibitors of the KSMP cleavage of C since they could 
sterically hinder the access of KSMP to the site of cleavage. 
Indeed, we found that while c~P-1 did not affect the cleavage 
at all (the rate was identical to that observed with the ccKLH 
antibodies, results not shown), the ~P-3 antibodies lowed the 
rate of the KSMP cleavage by about 50%. However, the ~P-2 
antibodies were found to block the KSMP cleavage (Fig. 4), a 
finding which will be useful in assessing the consequences of 
the KSMP cleavage of C and thus its physiological signifi- 
cance. 
3.5. Accessibility of  the P-l, P-2 and P-3 epitopes to the 
corresponding antibodies when C is in its native structure 
As seen in Fig. 2A, all three epitopes chosen in this study 
(P-l, P-2 and P-3) are accessible to interaction with the cor- 
responding antibodies (~P-1, aP-2, and aP-3) when C is in its 
unfolded (denatured) state, i.e., when C is stained by the anti- 
bodies after SDS-PAGE (Fig. 2A) However, when C is in its 
folded and catalytically active state, two of the antibodies 
react with C (~P-2, and c~P-3) and one (ctP-1) does not. As 
seen in Fig. 5A, when the cDNA of C was translated in a 
rabbit reticulocyte lysate system in the presence of 
[aSS]methionine and the 35S-labeled enzyme was subjected to 
immunoprecipitation with c~P-1, ~P-2, c~P-3, or c~KLH, an 
immunoprecipitate was obtained with either c~P-2 or c~P-3 
but not with c~P-1 (the 3sS-labeled precipitate obtained in 
this case was identical to that obtained with the antibodies 
against the carrier protein, KLH). The failure of the c@-i 
antibodies to precipitate C in its native structure, contrasted 
with the ability to stain C if it is pre-denatured, may be due to 
the fact that the P-1 epitope in the native structure of the 
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Fig. 3. Elucidation of the specificity of the aP-2 antibodies by immunostaining of deletion mutants of C. (A) Structure of the C deletion mu- 
tants used. Dashes indicate deleted amino acid residues; Cwt represents he wild type C structure; A4, A5, and A9 represent the structure of de- 
letion mutants of C lacking (respectively) the 4, 5, or 9 amino acid residues indicated. The underlined region in the Cwt structure corresponds 
to the sequence of the P-2 peptide that was used for the raising of the ~tP-2 antibodies. (B) Western blot analysis of the deletion mutants men- 
tioned in the above panel. The mutants were expressed in E. coli, and the whole bacterial ysate (5 ~tg) was subjected to SDS-PAGE and 
blotted onto nitrocellulose. The immunodetection was performed with the indicated antibodies (aP-3 and aP-2). The arrow (marked "C") indi- 
cates the position of Cwt, or of the indicated C mutants. 
enzyme (residues 6-23) may be inaccessible to interaction with 
the antibodies due to steric restrictions. In fact, this epitope is 
part of the A-helix which, in the mammalian enzyme struc- 
ture, is firmly anchored to the core of the enzyme, contribut- 
ing V15, F18 and L19 to the formation of the hydrophobic 
pocket accommodating the myristyl chain and anchoring it 
tightly to the enzyme [8]. 
3.6. Concluding remarks 
The aP-1 antibodies react equally well with C and with 
KSMP-cleaved C (C') when in the denatured state (e.g. on 
SDS-PAGE gels). However, they fail to react with C when it 
is in its native structure. Since the P-1 epitope (in helix A) has, 
at least in the myristylated mammalian enzyme, an important 
structural role in creating the hydrophobic pocket which ac- 
commodates the myristyl chain [8], and since the conforma- 
tion of this site may be altered if the myristyl chain is to be 
pulled out to allow the kinase to anchor itself to a hydropho- 
bic membrane, these antibodies may become useful for mon- 
itoring such conformational changes. In this context it should 
be mentioned that, in the non-myristylated recombinant en- 
zyme, the first 14 amino acid residues are not visible in the 
crystals [5,6], probably because of  a loosening in the structure. 
The ctP-2 antibodies, which are shown here to be specific to 
the 319K-F327 segment in C (very close to the KSMP cleavage 
site of the kinase, 332E-E333 [29]), act as an effective inhibitor 
of the cleavage. Thus they are useful for monitoring the con- 
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C' 
light 
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Fig. 4. Inhibition of the KSMP cleavage of C by ~P-2 and aP-3. A 
preparation of bovine C (0.5 ~tg) was preincubated (22°C, 30 rain) 
with the indicated antibodies (2 ~g), and then a KSMP cleavage 
was carried out (22°C, pH 7.1) for the indicated times (5, 15 and 45 
min). aKLH antibodies were used as a control for non-specific in- 
teraction. "Heavy chain" and "light chain" indicate (respectively) 
the position of the IgG heavy and light chains. 
270 
C 
Fig. 5. Biorecognition of the native conformation of C by the anti- 
peptide antibodies described in this study. The immunoprecipitation 
of native [35S]methionine-labeled C, translated in a rabbit reticulo- 
cyte translation mixture, was carried out using the indicated anti- 
bodies (aP-1, c~P-2, ctP-3, and aKLH). Each antibody (1 p-g) was 
bound to 5 p,1 of protein A sepharose, then 1 gl of the rabbit reticu- 
locyte translation mixture was added to the immunosorbent. "Put 
on" indicates the starting material (1 gl of the standard translation 
mixture) from which the C was immunoprecipitated. "C" indicates 
the position of intact native C. 
sequences of blocking the cleavage and for gaining an insight 
into the possible physiological role of KSMP. 
The coP-3 antibodies, which are shown above to react with 
C but not with C', provide us with the means of identifying 
the cleavage product of C by KSMP (C'). This inactive cleav- 
age product would stain with c~P-1 but not with c~P-3 and 
could be used to indicate the possible presence of KSMP in 
a certain tissue or at a given cellular locus. 
As a group, the anti-head and anti-tail antibodies described 
here provide us with a useful tool for the study of PKA itself, 
its conformational changes, and its possible regulation by a 
KSMP-like proteinase. Being epitope-specific antibodies based 
on distinct sequences outside the core of C (which shares a 
high homology with all members of the protein kinase family 
[3]), these antibodies are bound to be specific to C. Further- 
more, since they are directed against two distal segments of 
the molecule (the N-terminus and the C-terminus), their com- 
bined use provides a more restricted efinition of C and thus a 
greater degree of fidelity in biorecognition. 
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